Actively Recruiting
Comparison of Surgery Versus Cast Immobilization for Treating Medial Epicondyle Fractures in Children Aged 7 to 17
Led by Joseph Janicki · Updated on 2026-07-01
334
Participants Needed
1
Research Sites
30 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are comparing two treatments for medial epicondyle fractures in children aged 7 to 17 years. This injury, common in children and often caused by falls onto an outstretched hand, can lead to elbow dislocation and nerve issues. The study aims to find out whether surgery or non-surgical immobilization leads to better upper extremity function over one year. The trial is a multicenter, prospective, randomized and patient preference superiority study addressing a lack of clear evidence on optimal treatment. Participants will be assigned to one of two groups those receiving open reduction and internal fixation ORIF surgery using pin or screw fixation, and those treated with cast immobilization without surgery. The study involves randomization and includes detailed monitoring of treatment outcomes. Both treatment methods are being studied to determine their impact on healing and function. Throughout the study, participants will undergo assessments including the PROMIS Upper Extremity Function computer adaptive test at several intervals up to 36 months. Other measures include pain scores, radiographic healing checks, questionnaires on satisfaction, and tracking of any additional surgeries or complications. Safety oversight is provided by an independent board, and quality control ensures accurate data collection and reporting. Participation will last up to three years with regular follow-ups to evaluate outcomes comprehensively.
CONDITIONS
Brief Title
Cast or Operation for Medial Epicondyle Fracture Treatment in Children
Research Team
J
Jamie Burgess, PhD
M
Michelle Adzido, MA
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here